The table below summarizes the most recent Oncothyreon insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Oncothyreon insider buys are important for investors to follow.

Date	Insider	Price	Amount
6-1-2015 Insider Buy	Diana Hausman Chief Medical Officer	$4.65 CAGR »	$26,723.55 5,747 shares
3-26-2015 Insider Buy	Daniel K. Spiegelman Director	$1.61 CAGR »	$32,127.00 20,000 shares
12-17-2014 Insider Buy	Partners L. P/IL Bvf >10% Owner	$1.82 CAGR »	$688,678.86 378,444 shares
9-23-2014 Insider Buy	Jay Venkatesan EVP and General Manager	$2.00 CAGR »	$500,000.00 250,000 shares
11-1-2013 Insider Buy	Partners L. P/IL Bvf >10% Owner	$1.78 CAGR »	$229,620.00 129,000 shares
8-8-2013 Insider Buy	Partners L. P/IL Bvf >10% Owner	$1.65 CAGR »	$426,166.47 258,361 shares
8-1-2013 Insider Buy	Partners L. P/IL Bvf >10% Owner	$1.74 CAGR »	$589,602.29 338,087 shares
6-7-2013 Insider Buy	Partners L. P/IL Bvf >10% Owner	$1.81 CAGR »	$387,225.98 214,467 shares

Also See: Institutional Holders of ONTY
Also See: SEC filings

Below we present the annualized performance delivered by Oncothyreon stock since 6-1-2015 (the date of the most recent insider purchase). The performance of the investment from the time Oncothyreon insider buying occurred is the ultimate test of whether insiders were right about ONTY being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	06/02/2015
End date:	06/08/2016
Start price/share:	$3.94
End price/share:	$1.21
Dividends collected/share:	$0.00
Total return:	-69.29%
Average Annual Total Return:	-68.60%
Starting investment:	$10,000.00
Ending investment:	$3,071.01
Years:	1.02

Oncothyreon Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Oncothyreon insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding ONTY

ONTY — Current Quote

Quotes delayed 20 minutes

Free ONTY Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

ONTY — Performance

More Insider Buying

Other companies seeing insider buying close in time to when the Oncothyreon Insider Buying occurred are:

ShoreTel Insider Buying
Otonomy Insider Buying
Skystar Bio-Pharmaceutical Insider Buying
Precision Castparts Insider Buying
Cadence Design Systems Insider Buying
QLogic Insider Buying
ABIOMED Insider Buying
Bi-Optic Ventures Insider Buying
Community Bank Shares of Indiana Insider Buying
OsiriTSC

Oncothyreon Insider Buying

Oncothyreon Insider Buying | www.HoldingsChannel.com